Pregnancy category of nicotine replacement therapy?

• A. A
• B. B
• C. C
• D. D

Answer: (D)

The main idea is understanding how nicotine replacement therapy is labeled for use in pregnancy and what that labeling means for risk and benefit. Nicotine itself can affect fetal development, so there is documented fetal risk when nicotine is used during pregnancy. However, in a pregnant person who is trying to quit smoking, using nicotine replacement therapy can reduce exposure to the many harmful substances found in tobacco smoke, potentially lowering overall harm to the fetus compared with continued smoking.

Because there is evidence of fetal risk with nicotine exposure, but a real potential benefit from helping the person stop smoking (and thus reducing other smoke-related toxins), the appropriate category reflects that balance. That’s why the pregnancy category is D: there is risk, but use may be warranted if the benefits (smoking cessation and reduced exposure to smoke toxins) outweigh the risks.

Other categories would imply no risk or unclear risk without a clear potential benefit, which doesn’t align with the need to weigh harm reduction against fetal risk in this scenario.